LENZ
LENZ Therapeutics Inc.

1,225
Mkt Cap
$512.22M
Volume
801,785.00
52W High
$50.40
52W Low
$15.70
PE Ratio
-8.10
LENZ Fundamentals
Price
$17.07
Prev Close
$16.37
Open
$16.60
50D MA
$28.85
Beta
1.16
Avg. Volume
1.3M
EPS (Annual)
-$2.34
P/B
2.52
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
LENZ Therapeutics (NASDAQ:LENZ) Shares Up 5% - What's Next?
LENZ Therapeutics (NASDAQ:LENZ) Shares Up 5% - Time to Buy...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Moderate Buy" by Analysts
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are presently covering the firm, MarketBeat reports...
MarketBeat·2d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Sees Large Volume Increase - Should You Buy?
LENZ Therapeutics (NASDAQ:LENZ) Sees Strong Trading Volume - Time to Buy...
MarketBeat·5d ago
News Placeholder
Stempoint Capital LP Buys Shares of 183,912 LENZ Therapeutics, Inc. $LENZ
Stempoint Capital LP bought a new position in LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·9d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 6.3% - Here's What Happened
LENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 6.3% - Time to Sell...
MarketBeat·22d ago
News Placeholder
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Rating of "Moderate Buy" by Brokerages
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven research firms that are currently covering the stock, Marketbeat reports...
MarketBeat·25d ago
News Placeholder
Zacks Research Downgrades LENZ Therapeutics (NASDAQ:LENZ) to Hold
Zacks Research cut LENZ Therapeutics from a "strong-buy" rating to a "hold" rating in a report on Thursday...
MarketBeat·26d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Insider Shawn Olsson Sells 10,000 Shares
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) insider Shawn Olsson sold 10,000 shares of LENZ Therapeutics stock in a transaction dated Monday, November 17th. The shares were sold at an...
MarketBeat·29d ago
News Placeholder
Candriam S.C.A. Takes $5.02 Million Position in LENZ Therapeutics, Inc. $LENZ
Candriam S.C.A. purchased a new position in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·1mo ago
News Placeholder
Calamos Advisors LLC Makes New $515,000 Investment in LENZ Therapeutics, Inc. $LENZ
Calamos Advisors LLC acquired a new stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange...
MarketBeat·1mo ago
<
1
2
...
>

Latest LENZ News

View

Advertisement|Remove ads.

Advertisement|Remove ads.